 |
인쇄하기
취소
|
Dongwha to transfer DW224a technologies to U. S.
Dongwha has developed a new quinolone antibacterial agent, DW225a and recently made its technology transfer agreement with American Pacific Beach BioScience on June 13.
Dongwha's stocks ever rose up after the announcement of its technology transfer to Pacific Beach BioScience on June 13.
Dongwha will get about 56,500 thousand U. S. dollars (about 52,500 mil. won) of a frontal payment, a m...
Dongwha's stocks ever rose up after the announcement of its technology transfer to Pacific Beach BioScience on June 13.
Dongwha will get about 56,500 thousand U. S. dollars (about 52,500 mil. won) of a frontal payment, a m...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.